Latest News Archive
Please select Category, Year, and then Month to display items
![]()
Prof Stef Coetzee, former Rector and Vice-Chancellor of the University of the Free State (UFS), passed away in the Mediclinic Cape Gate on Saturday 27 October 2018.
Prof Coetzee assumed duty as the 11th Rector and Vice-Chancellor of the UFS on 1 April 1997. He will be remembered for his drive to promote transformation at the UFS. During his time as Rector and Vice-Chancellor, he initiated a revitalisation process (turnaround strategy) which was ultimately finalised by his successor, Prof Frederick Fourie.
Among others, he established a Broad Transformation Forum (BTF) and transformation office to draft a new political framework for the UFS. He strived to manage the university as a business enterprise and was focused on developing the academy in an entrepreneurial manner. His legacy includes the establishment of the BTF, the revitalisation process (turnaround strategy), academic revitalisation, growing student numbers, and increased research outputs. He stepped down as Rector at the end of 2002.
“The turnaround strategy initiated by Prof Coetzee during his term as Rector and Vice-Chancellor is still evident today in the management approach of the UFS. On behalf of the executive management and the university community, I wish his family, relatives, and former colleagues all the best during this difficult and sad time. I hope that they will find comfort in his significant contribution to various sectors in the country – especially at the UFS,” said Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.
Prof Stef Coetzee obtained his MA degree in Economics at Stellenbosch University in 1973, and a DPhil in Development Economics at the University of the Free State (UFS) in 1980. He is a former Executive Officer of the Afrikaanse Handelsinstituut and was also associated with Unisa and the North-West University.
Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”